MedWatch Safety Alerts
All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
If a drug product marketed as sterile has microbial contamination, patient is at risk of serious infection.
Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
Patients are at increased risk of infection in the event a sterile product is compromised.
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
UPDATED 05/14/2013. FDA has approved label changes specifying new dosing recommendations for zolpidem products.
Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and Soy
Risk of serious or life-threatening allergic reaction.
The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
These products should not be administered to patients. If a drug product marketed as sterile has microbial contamination, it potentially places patients at risk of serious infection.
SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
Undeclared tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
Bullet Proof: Public Notification - Undeclared Drug Ingredient
Testing revealed the product contains tadalafil, which may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.
